Search results
Results from the WOW.Com Content Network
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage).
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures. The brand and its generic ...
Mexico – Epival and Epival ER (extended release) by Abbott Laboratories; United Kingdom – Depakote (for psychiatric conditions) and Epilim (for epilepsy) by Sanofi-Aventis and generics; United States – Depakote and Depakote ER (extended release) by Abbott Laboratories and generics [4]
divalproex sodium: Depakote 10 March 1983 [56] eslicarbazepine: Aptiom 11 August 2013 [57] [58] ethosuximide: Zarontin 2 November 1960 [59] 1955 [46] 1962 [51] ethotoin: Peganone 22 April 1957 [60] everolimus: Afinitor/Votubia 30 January 2009 [61] felbamate: Felbatol 29 July 1993 [62] fosphenytoin: Cerebyx
For premium support please call: 800-290-4726 more ways to reach us
The 22.7 billion-peso figure would amount to just short of $1 billion in dollars if using the government’s exchange rate for state enterprises, currently set at 24 pesos to the dollar.
This page was last edited on 17 June 2015, at 07:32 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may ...
“The currency conversion is thus made by the DCC provider, using the DCC provider’s exchange rate, without the customer’s knowledge.” Consumers take a hit to their pocketbooks as a result.